BUSINESSSTAT NEWS
STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
- China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
- China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials